Pashtoon Kasi MD, MS Profile picture
Aug 6 8 tweets 4 min read Twitter logo Read on Twitter
What is the #CityOfHopeDrug?

A pill💊that can kill all #cancers.

I have been asked the "killer-pill" question several times this week. What is the hope or the hype?

Let’s learn together:
👇Here’s a tweetorial: @OncoAlert

Press release: August 1, 2023:
https://t.co/o5HNKEgIApcityofhope.org/city-hope-scie…
Image
The study was published in the journal Cell Chemical and Biology.

"Small molecule targeting of transcription-replication conflict for selective chemotherapy."

Link to journal article:


It targets DNA🧬 replication/transcription simplistically speaking. https://t.co/5HEcipZRpVcell.com/cell-chemical-…
Image
What did the authors @cityofhope find?

They have discovered/designed a new key🔑(inhibitor called AOH1996) for this particular lock🔒called PCNA (Proliferating cell nuclear antigen).

This molecule plays an important role in the formation and repair of DNA🧬.

Sequel to AOH1160. Image
In the paper, they report anti-tumor effects in 70 cell lines. However, to be specific, these were the following 9 cancers:

1. Leukemia
2. Lung
3. Colon
4. Brain
5. Melanoma
6. Ovarian
7. Kidney
8. Prostate
9. Breast

Also, xenograft experiments were done in mice/3 tumor types. Image
The new pill (AOH1996)💊 works on its own as well as sensitizes to this class of drugs called topoisomerase inhibitors. The latter is also involved in DNA 🧬damage/replication axis.

They also synergize with other drugs like cisplatin which are also considered DNA damaging. Image
One experiment of note, the drug actually didn't perform superior to one of the old chemotherapy drugs that we seldom use (CPT-11 or commonly called Topotecan).

The light blue line is the old chemo drug. It did better compared to the new pill (shown in red).
34.6%🆚11.5%. Image
What is my take?

I will just leave the final sentences from the authors themselves: copied/pasted:

"...We acknowledge that positive animal study results do NOT always translate into success in treating cancer patients. Future clinical studies are necessary..." Image
But I think the bigger issue is that this much hype to a pre-clinical study is not justified. Somewhat premature.

I am all about clinical trials and would I offer this new killer-pill as part of a trial to my patients? Absolutely✅.

Is it ready to cure all? No, unfortunately. Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Pashtoon Kasi MD, MS

Pashtoon Kasi MD, MS Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @pashtoonkasi

Mar 31, 2022
Yesterday at #TargetedChat we talked about a challenging case of a young individual with recurrent UNRESECTABLE colon cancer after adjuvant.

Here’s a 🧵 on the questions/answers. No one right away. What would you do differently?👇🏾Read/reply along #ColorectalCancerAwarenessMonth Image
It was interesting to see the distribution on the chemo backbone options.

TRIPLETS 🆚 DOUBLETS #TargetedChat #CRCSM Image
👇🏾With the doublets and triplets discussion, a little bit of art 🖼 to the science 🧪

Have to see and individualize in each patient which tools 🛠 from the toolbox 🧰.

#TargetedChat #CRCSM #ColorectalCancer #ColorectalCancerAwarenessMonth Image
Read 9 tweets
Jan 15, 2021
#GI21 time for another #Tweetorial🧵 on

#LiquidBiopsies
#CirculatingTumorDNA
#ctDNA

in a very 🎯 “Target-rich” disease
#Cholangiocarcinoma
#HPBCSM

~3️⃣0️⃣% actionable findings

Interestingly we found more #FGFR🧬 fusions on liquid🩸than tissue 🔬. #OncoAlert
@TempusLabs
🧵2️⃣ #GI21
#Cholangiocarcinoma is the poster child of actionable aberrations & truly a 🎯“Target-rich” disease.

We focused on %numbers for aberrations for which there’s either an ✅approved drug, guideline endorsement, #clinicaltrials or even off-label reports/cases.👇🏾
🧵3️⃣ #GI21
We often don’t think of #ctDNA based platforms to be as sensitive for detecting fusions; when present it is real & an actionable finding.

Interestingly we found #FGFR🧬fusions
🩸LIQUID>>TISSUE🔬
💭 maybe because of selection bias. #ctDNA filling the void. #OncoAlert
Read 12 tweets
Jul 1, 2020
Bird’s-eye view 👁 on what to look out for @WCGIC #WorldGI2020.
Opening remarks on important data 📺 @myESMO - by Dr. Eric Van Cutsem @UZLeuven.
🟩Good to see more #PrecisionMedicine🧬
🟥#Immunotherapy #Immuno-#oncology
🟦TNT & other chemo strategies
@Annals_Oncology #OncoAlert
🆕#ctDNA #liquidbiopsies 🩸🧬
👀 👇🏾at the number of #clinicaltrials cropping up in this space‼️
🇦🇺DYNAMIC-II
🇦🇺DYNAMIC-III
🇺🇸COBRA @NRGonc
🇺🇸BESPOKE
🇺🇸@SU2C
🇯🇵 CIRCULATE
🌎COLUMBIA
🇮🇹🇪🇸PEGASYS
🇬🇧TRACC
🇩🇪CIRCULATE
🇫🇷crEATE
🇩🇰IMPROVE-IT
We have 2🇺🇸studies open. #CRCSM #WorldGI2020
#WORLDGI2020 This is 🆒 ☢️ 32-P EUS-guided implantation in #pancreascancer #PANCSM @myESMO @WCGIC @Annals_Oncology.

Still miles to go. OS median of 16 months pointing again to the systemic nature of disease. Need to piggyback these local approaches to better systemic. #OncoAlert
Read 55 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(